title: Primary pulmonary malignant hemangiopericytoma associated with coagulopathy.
abstract: A 34-year-old woman with a massive pulmonary malignant hemangiopericytoma and coagulopathy as a paraneoplastic syndrome is reported. Although coagulopathy may appear as a paraneoplastic syndrome and cause treatment to be more complicated and difficult, it can also be a useful marker to monitor the results of operation and tumor recurrence. This unusual case shows that primary pulmonary malignant hemangiopericytoma deserves aggressive surgical intervention with complete resection even under the circumstances of coagulation abnormality.
authors.affiliation: Department of Surgery, Veterans General Hospital-Taipei, Taiwan, Republic of China.
authors.forename: Y C
authors.initials: YC
authors.lastname: Wu
authors.forename: L S
authors.initials: LS
authors.lastname: Wang
authors.forename: W
authors.initials: W
authors.lastname: Chen
authors.forename: H J
authors.initials: HJ
authors.lastname: Fahn
authors.forename: M H
authors.initials: MH
authors.lastname: Huang
authors.forename: J
authors.initials: J
authors.lastname: Whang-Peng
mesh_terms: D000328:Adult; D000933:Antifibrinolytic Agents / Q000097:blood; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000209:etiology*; D001780:Blood Coagulation Tests; D016063:Blood Loss, Surgical; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D005340:Fibrinogen / Q000032:analysis; D005342:Fibrinolysis; D006393:Hemangiopericytoma / Q000150:complications* / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D009364:Neoplasm Recurrence, Local / Q000473:pathology; D010257:Paraneoplastic Syndromes / Q000209:etiology*; D011013:Pneumonectomy; D019106:Postoperative Hemorrhage / Q000209:etiology; D013924:Thrombophlebitis / Q000209:etiology
chemical_list: D000933:Antifibrinolytic Agents; D005338:Fibrin Fibrinogen Degradation Products; C036309:fibrin fragment D; D005340:Fibrinogen